Rödl & Partner advises Swedish AVIA Pharma on the acquisition of ALLERGIKA Pharma


Munich/Stockholm, 25 August 2022: Rödl & Partner advised Swedish AVIA Pharma AB on the acquisition of ALLERGIKA Pharma GmbH, a medium-sized, family-owned pharmaceutical company with products for the prevention and treatment of allergies and skin diseases.


As part of the advisory services, AVIA Pharma was supported by a specialised, cross-disciplinary transaction team from Rödl & Partner in legal, tax and financial transaction issues. Partner Thomas Fräbel (Munich) provided comprehensive legal (purchase) contract drafting and negotiation support including support on the acquisition financing. The overall project management, the financial due diligence as well as the business consulting was led by partner Matthias Zahn, the tax due diligence as well as the structural tax consulting by partner Dr Dagmar Möller-Gosoge (both Munich).
“By acquiring Allergika, we are taking a big step towards realizing our strategy of building a northern European pharmaceutical company. This deal gives us a great platform for further expansion in the DACH region. Allergika’s products are very well known throughout the medical community, especially among dermatologist and allergologists as well as pharmacists and the products are very appreciated by patients in Germany. We will continue to build upon Allergika’s strong market position and further develop the company” says Jacob Calmvik, CEO of Avia Pharma

About AVIA Pharma AB

Avia Pharma AB is a Swedish sales and marketing company that has been active in the Scandinavian region since its foundation in 2016. Avia Pharma AB partners with research, biotech and pharmaceutical companies in the individual licensing and acquisition of OTC and prescription drugs. According to the company’s own statement, the main areas of focus are women’s health, urology, dermatology and general OTC. 

About ALLERGIKA Pharma GmbH

ALLERGIKA Pharma GmbH, based in Wolfratshausen, is a medium-sized pharmaceutical company with products for the prevention and treatment of allergies and skin diseases. The company was founded 25 years ago and, according to its own information, employs around 70 people.

Consultant AVIA Pharma

Rödl & Partner

Thomas Fräbel, Partner (M&A, Financing), Munich, Lead Legal – Legal
Elisabeth Schmidt, Associate Partner (Corporate/M&A), Munich – Legal
Alexander von Chrzanowski, Associate Partner (IP, IT), Jena – Legal
Juliane Krafft, Senior Associate (Corporate/M&A, Labor Law), Munich – Legal
Malte Kroll, Associate (Corporate/M&A), Munich – Legal
Alexandra Kremer, Associate (Corporate/M&A), Munich – Legal
Mathias Zahn, Partner (Financial, TVS), Munich, Overall project management, Lead Financial – Financial
Fabio Franzoi, Senior Associate (TVS), Munich – Financial
Lisa Eisen, Associate (TS), Munich – Financial
Dr Dagmar Möller-Gosoge, Partner (Tax), Munich, Lead Tax – Tax
Dr Susann Sturm, Senior Associate (Tax), Munich – Tax


Contact Person Picture

Matthias Zahn


+49 89 9287 802 15

Send inquiry

Contact Person Picture

Thomas Fräbel


+49 89 9287 803 14
+49 89 9287 806 66

Send inquiry

Contact Person Picture

Dr. Dagmar Möller-Gosoge

Partner, US Desk

+49 89 9287 80 551

Send inquiry

Deutschland Weltweit Search Menu